The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. Year to date metric has recorded a gain of 50.44%.However, over the last six months, we can see a weaker performance of 12.46%. Over the last 30 days, the price of YTEN has fallen by 41.18%. And in the last five days, it has surged by 45.16%.
Yield10 Bioscience Inc experienced a rather shaky stock market performance. The highest value in the past year was recorded at $3.29 on 05/11/23 and the lowest value was $0.18 on 12/11/23.
52-week price history of YTEN Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Yield10 Bioscience Inc’s current trading price is -89.06% away from its 52-week high, while its distance from the 52-week low is 100.00%. The stock’s price range during this period has varied between$0.18 and $3.29. The Yield10 Bioscience Inc’s shares, which operate in the Basic Materials, saw a trading volume of around 2.08 million for the day, a figure considerably lower than their average daily volume of 4.47 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Yield10 Bioscience Inc (YTEN) has experienced a quarterly rise of 76.47% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 4.31M and boasts a workforce of 30 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.2535, with a change in price of +0.0500. Similarly, Yield10 Bioscience Inc recorded 2,986,430 in trading volume during the last 100 days, posting a change of +16.13%.
YTEN’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for YTEN stands at 8.54. Similarly, the long-term debt-to-equity ratio is also 4.36.
YTEN Stock Stochastic Average
Yield10 Bioscience Inc’s raw stochastic average for the past 50 days is presently 32.77%, as of today. This marks a increase from the raw stochastic average of the last 20 days, which was 28.67%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 34.60% and 35.08%, respectively.
